Cargando…
Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens
Tuberculosis (TB) continues to be one of the deadliest infectious diseases in the world, causing ~1.5 million deaths every year. The World Health Organization initiated an End TB Strategy that aims to reduce TB-related deaths in 2035 by 95%. Recent research goals have focused on discovering more eff...
Autores principales: | Budak, Maral, Cicchese, Joseph M., Maiello, Pauline, Borish, H. Jacob, White, Alexander G., Chishti, Harris B., Tomko, Jaime, Frye, L. James, Fillmore, Daniel, Kracinovsky, Kara, Sakal, Jennifer, Scanga, Charles A., Lin, Philana Ling, Dartois, Véronique, Linderman, Jennifer J., Flynn, JoAnne L., Kirschner, Denise E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306236/ https://www.ncbi.nlm.nih.gov/pubmed/37319311 http://dx.doi.org/10.1371/journal.pcbi.1010823 |
Ejemplares similares
-
In silico evaluation and exploration of antibiotic tuberculosis treatment regimens
por: Pienaar, Elsje, et al.
Publicado: (2015) -
Both Pharmacokinetic Variability and Granuloma Heterogeneity Impact the Ability of the First-Line Antibiotics to Sterilize Tuberculosis Granulomas
por: Cicchese, Joseph M., et al.
Publicado: (2020) -
Comparing efficacies of moxifloxacin, levofloxacin and gatifloxacin in tuberculosis granulomas using a multi-scale systems pharmacology approach
por: Pienaar, Elsje, et al.
Publicado: (2017) -
T cell transcription factor expression evolves over time in granulomas from Mycobacterium tuberculosis-infected cynomolgus macaques
por: Grant, Nicole L., et al.
Publicado: (2022) -
A multi-scale pipeline linking drug transcriptomics with pharmacokinetics predicts in vivo interactions of tuberculosis drugs
por: Cicchese, Joseph M., et al.
Publicado: (2021)